“Long-Term Safety of Sonidegib in Basal Cell Carcinoma: 30-Month Results from the BOLT Trial”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S47. https://doi.org/10.25251/skin.2.supp.47.